GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Beijing Science Sun Pharmaceutical Co Ltd (SZSE:300485) » Definitions » 3-Year EPS without NRI Growth Rate

Beijing Science Sun Pharmaceutical Co (SZSE:300485) 3-Year EPS without NRI Growth Rate : 0.00% (As of Mar. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Beijing Science Sun Pharmaceutical Co 3-Year EPS without NRI Growth Rate?

Beijing Science Sun Pharmaceutical Co's EPS without NRI for the three months ended in Mar. 2024 was ¥-0.13.

During the past 12 months, Beijing Science Sun Pharmaceutical Co's average EPS without NRI Growth Rate was -108.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.

During the past 13 years, the highest 3-Year average EPS without NRI Growth Rate of Beijing Science Sun Pharmaceutical Co was 30.20% per year. The lowest was -84.50% per year. And the median was -0.80% per year.


Competitive Comparison of Beijing Science Sun Pharmaceutical Co's 3-Year EPS without NRI Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Beijing Science Sun Pharmaceutical Co's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Beijing Science Sun Pharmaceutical Co's 3-Year EPS without NRI Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Beijing Science Sun Pharmaceutical Co's 3-Year EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where Beijing Science Sun Pharmaceutical Co's 3-Year EPS without NRI Growth Rate falls into.



Beijing Science Sun Pharmaceutical Co 3-Year EPS without NRI Growth Rate Calculation

This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.


Beijing Science Sun Pharmaceutical Co  (SZSE:300485) 3-Year EPS without NRI Growth Rate Explanation

EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.


Beijing Science Sun Pharmaceutical Co 3-Year EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of Beijing Science Sun Pharmaceutical Co's 3-Year EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Beijing Science Sun Pharmaceutical Co (SZSE:300485) Business Description

Traded in Other Exchanges
N/A
Address
No. 8, Xingsheng Street, Yizhuang Economic and Technological Development Zone, Beijing, CHN, 100176
Beijing Science Sun Pharmaceutical Co Ltd is engaged in the research and development, production and sales of biological drugs. The company products can be divided into cardiovascular series, immune regulation series, nervous system series, and other natural or biotech pharmaceuticals. Its products include Injection Tiopronin, Cybex, Xel, Lichinga, Plasmin Injection and Race liter.
Executives
Ma Li Directors, executives
Kong Shuang Quan Executives
Li Jian Hua Director
Ma Biao Directors, executives
Li Zhi Bing Supervisors
Zhang Fan Executives

Beijing Science Sun Pharmaceutical Co (SZSE:300485) Headlines

No Headlines